½ÃÀ庸°í¼­
»óǰÄÚµå
1770839

¶óº§ ÇÁ¸® ¾î·¹ÀÌ ½Ã½ºÅÛ ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, °æÀï, ±âȸ, ¿¹Ãø : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)

Label-free Array Systems Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Type, By Application, By End user, By Region & Competition, 2020-2030F

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechSci Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 180 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¶óº§ ÇÁ¸® ¾î·¹ÀÌ ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2024³â¿¡´Â 5¾ï 3,026¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2030³â¿¡´Â 8¾ï 1,411¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È CAGR 7.41%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¶óº§ ÇÁ¸® ¾î·¹ÀÌ ½Ã½ºÅÛÀº Çü±¤ Ç¥Áö³ª ¹æ»ç¼º Ç¥Áö ¾øÀÌ »ýüºÐÀÚ¸¦ ½Äº°Çϰí Á¤·®È­Çϱâ À§ÇØ »ç¿ëµÇ´Â ÷´Ü ºÐ¼® µµ±¸ÀÔ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ÁַΠǥ¸é ÇöóÁî¸ó °ø¸í(SPR) ¿ø¸®·Î ÀÛµ¿Çϸç, ¹Ý»ç±¤ÀÇ º¯È­¸¦ ÅëÇØ »ýüºÐÀÚ »óÈ£ÀÛ¿ëÀ» ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·á, ½Å¼ÓÇÑ ÀǾàǰ °³¹ß, ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö, ƯÁ¤ ´Ü¹éÁú ½Äº°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿¬±¸ ¹× ½Å¾à°³¹ß¿¡ ¶óº§ÀÌ ÇÊ¿ä ¾ø´Â ±â¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. º¹ÀâÇÑ »ý¹°ÇÐÀû »ùÇÿ¡ ´ëÇÑ ¿ªµ¿ÀûÀ̰í Á¤È®ÇÑ ºÐ¼®À» Á¦°øÇÏ´Â ´É·ÂÀº Çö´ë »ý¹° ÀÇÇÐ ¿¬±¸¿¡ ÇʼöÀûÀÎ µµ±¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 5¾ï 3,026¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 8¾ï 1,411¸¸ ´Þ·¯
CAGR : 2025-2030³â 7.41%
±Þ¼ºÀå ºÎ¹® CRO(ÀǾàǰ ÀÓ»ó½ÃÇè¼öʱâ°ü)
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ÃËÁø¿äÀÎ

½Å¾à°³¹ß¿¡¼­ ½Ç½Ã°£, °í󸮷® ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

ÁÖ¿ä ½ÃÀå °úÁ¦

°í°¡ÀÇ Àåºñ ¹× ÀÎÇÁ¶ó ¿ä±¸ »çÇ×

ÁÖ¿ä ½ÃÀå µ¿Çâ

µ¥ÀÌÅÍ ÇØ¼®À» À§ÇÑ ÀΰøÁö´É ¹× ¸Ó½Å·¯´×°úÀÇ ÅëÇÕ

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ¼¼°èÀÇ ¶óº§ ÇÁ¸® ¾î·¹ÀÌ ½Ã½ºÅÛ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • À¯Çüº°(Ç¥¸é ÇöóÁî¸ó °ø¸í, ¹ÙÀÌ¿À Ãþ °£¼·¹ý, ¼¼Æ÷À¯ÀüºÐ±¤¹ý µî)
    • ¿ëµµº°(Drug Discovery, ´Ü¹éÁú °è¸éºÐ¼®, Ç×ü Ư¼º Æò°¡ µî)
    • ÃÖÁ¾»ç¿ëÀÚº°(Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷, ÇмúÁ¶»ç±â°ü, ÀÓ»ó½ÃÇè¼öʱâ°ü µî)
    • ±â¾÷º°(2024)
    • Áö¿ªº°
  • ½ÃÀå ¸Ê

Á¦6Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¶óº§ ÇÁ¸® ¾î·¹ÀÌ ½Ã½ºÅÛ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º° ºÐ¼®
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • ÀϺ»
    • È£ÁÖ

Á¦7Àå À¯·´ÀÇ ¶óº§ ÇÁ¸® ¾î·¹ÀÌ ½Ã½ºÅÛ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • À¯·´ : ±¹°¡º° ºÐ¼®
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ

Á¦8Àå ºÏ¹ÌÀÇ ¶óº§ ÇÁ¸® ¾î·¹ÀÌ ½Ã½ºÅÛ ½ÃÀå Àü¸Á.

  • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • ºÏ¹Ì : ±¹°¡º° ºÐ¼®
    • ¹Ì±¹
    • ¸ß½ÃÄÚ
    • ij³ª´Ù

Á¦9Àå ³²¹ÌÀÇ ¶óº§ ÇÁ¸® ¾î·¹ÀÌ ½Ã½ºÅÛ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • ³²¹Ì : ±¹°¡º° ºÐ¼®
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¶óº§ ÇÁ¸® ¾î·¹ÀÌ ½Ã½ºÅÛ ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° ºÐ¼®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®

Á¦11Àå ½ÃÀå ¿ªÇÐ

  • ¼ºÀå ÃËÁø¿äÀÎ
  • °úÁ¦

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

  • ÃÖ±Ù µ¿Çâ
  • ÀμöÇÕº´
  • Á¦Ç° °³¹ß

Á¦13Àå Porter's Five Forces ºÐ¼®

  • ¾÷°è³» °æÀï
  • ½Å±Ô Âü¿©ÀÇ °¡´É¼º
  • °ø±Þ¾÷üÀÇ ´É·Â
  • °í°´ÀÇ ´É·Â
  • ´ëüǰÀÇ À§Çù/¼­ºñ½º

Á¦14Àå ¶óº§ ÇÁ¸® ¾î·¹ÀÌ ½Ã½ºÅÛ ½ÃÀå : SWOT ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Sartorius AG

Á¦16Àå Àü·«Àû Á¦¾È

Á¦17Àå Á¶»ç ȸ»ç ¼Ò°³ ¹× ¸éÃ¥»çÇ×

ksm

The Global Label-free Array Systems Market was valued at USD 530.26 million in 2024 and is projected to reach USD 814.11 million by 2030, growing at a CAGR of 7.41% during the forecast period. Label-free array systems are advanced analytical tools used for identifying and quantifying biomolecules without the need for fluorescent or radioactive labels. These systems operate primarily on the principle of Surface Plasmon Resonance (SPR), enabling real-time monitoring of biomolecular interactions through changes in reflected light. Increasing demand for personalized medicine, rapid drug development, biomarker discovery, and specific protein identification is driving the adoption of label-free technologies in research and drug discovery. Their ability to deliver dynamic, accurate analysis in complex biological samples positions them as indispensable tools in modern biomedical research.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 530.26 Million
Market Size 2030USD 814.11 Million
CAGR 2025-20307.41%
Fastest Growing SegmentContract Research Organizations (CROs)
Largest MarketNorth America

Key Market Drivers

Increasing Demand for Real-Time, High-Throughput Analysis in Drug Discovery

The rising need for real-time, high-throughput screening technologies in pharmaceutical and biotechnological research is a major driver of the label-free array systems market. Traditional labeled assays are time-intensive and susceptible to inaccuracies due to interference from the labels themselves. Label-free array systems overcome these limitations by allowing direct observation of biomolecular interactions without tagging, providing valuable kinetic data. This is especially critical in early drug discovery stages where understanding drug-target affinities and interaction profiles can guide lead compound selection and optimization, significantly accelerating the development pipeline.

Key Market Challenges

High Cost of Equipment and Infrastructure Requirements

Despite offering cutting-edge capabilities, label-free array systems come with high capital and operational costs. The instruments often require specialized detection components-optical, acoustic, or electrochemical-which demand substantial financial investment and maintenance. Moreover, these systems frequently need controlled lab environments such as clean rooms or vibration-free setups, further increasing infrastructure costs. These financial constraints can hinder adoption in small- to mid-sized research facilities and institutions, particularly in low- and middle-income regions. Even in developed countries, funding limitations pose challenges for academia and SMEs unless supported by grants or partnerships, which remain competitive and limited in availability.

Key Market Trends

Integration with Artificial Intelligence and Machine Learning for Data Interpretation

The incorporation of artificial intelligence (AI) and machine learning (ML) technologies into label-free array systems is transforming how large-scale biological data is analyzed. These systems produce vast and complex datasets, particularly in proteomics and biomarker discovery. AI-driven analytics streamline data processing by detecting subtle patterns, improving signal clarity, and reducing background noise. This trend enhances both the accuracy and speed of research outputs. Globally, regulatory and research bodies are promoting AI integration in healthcare. The FDA's Digital Health Center of Excellence and the European Commission's Digital Europe Programme-with a €7.5 billion allocation-are key initiatives advancing AI-based biomedical innovation, supporting broader adoption of intelligent data analytics in label-free platforms.

Key Market Players

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Sartorius AG

Report Scope:

In this report, the Global Label-free Array Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Label-free Array Systems Market, By Type:

  • Surface Plasmon Resonance
  • Bio-layer Interferometry
  • Cellular Dielectric Spectroscopy
  • Others

Label-free Array Systems Market, By Application:

  • Drug Discovery
  • Protein Interface Analysis
  • Antibody Characterization
  • Others

Label-free Array Systems Market, By End User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institute
  • Contract Research Organization
  • Others
  • Ambulatory Care Centers
  • Others

Label-free Array Systems Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Label-free Array Systems Market.

Available Customizations:

Global Label-free Array Systems Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered.
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Label-free Array Systems Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (surface plasmon resonance, bio-layer interferometry, cellular dielectric spectroscopy, and others)
    • 5.2.2. By Application (Drug Discovery, Protein Interface Analysis, Antibody Characterization and Others)
    • 5.2.3. By End user (Pharmaceutical and Biotechnology Companies, Academic and Research Institute, Contract Research Organization and Others)
    • 5.2.4. By Company (2024)
    • 5.2.5. By Region
  • 5.3. Market Map

6. Asia-Pacific Label-free Array Systems Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End user
    • 6.2.4. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Label-free Array Systems Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End user
    • 6.3.2. India Label-free Array Systems Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End user
    • 6.3.3. South Korea Label-free Array Systems Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End user
    • 6.3.4. Japan Label-free Array Systems Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By Application
        • 6.3.4.2.3. By End user
    • 6.3.5. Australia Label-free Array Systems Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By Application
        • 6.3.5.2.3. By End user

7. Europe Label-free Array Systems Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End user
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Label-free Array Systems Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End user
    • 7.3.2. Germany Label-free Array Systems Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End user
    • 7.3.3. United Kingdom Label-free Array Systems Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End user
    • 7.3.4. Italy Label-free Array Systems Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End user
    • 7.3.5. Spain Label-free Array Systems Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End user

8. North America Label-free Array Systems Market Outlook.

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End user
    • 8.2.4. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Label-free Array Systems Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End user
    • 8.3.2. Mexico Label-free Array Systems Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End user
    • 8.3.3. Canada Label-free Array Systems Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End user

9. South America Label-free Array Systems Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End user
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Label-free Array Systems Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End user
    • 9.3.2. Argentina Label-free Array Systems Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End user
    • 9.3.3. Colombia Label-free Array Systems Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End user

10. Middle East and Africa Label-free Array Systems Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End user
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Label-free Array Systems Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End user
    • 10.3.2. Saudi Arabia Label-free Array Systems Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End user
    • 10.3.3. UAE Label-free Array Systems Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products/Services

14. Label-free Array Systems Market: SWOT Analysis

15. Competitive Landscape

  • 15.1. Illumina, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Thermo Fisher Scientific, Inc.
  • 15.3. Agilent Technologies, Inc.
  • 15.4. PerkinElmer, Inc.
  • 15.5. Merck KGaA
  • 15.6. Danaher Corporation
  • 15.7. Bio-Rad Laboratories, Inc.
  • 15.8. F. Hoffmann-La Roche Ltd.
  • 15.9. Becton, Dickinson and Company
  • 15.10. Sartorius AG

16. Strategic Recommendations

17. About Us & Disclaimer

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦